Books and Reviews
Berson SA, Yalow RS. Peptide hormones in plasma. Harvey Lect. 1966–1967;62:107–163.
Farfel Z, Bourne HR, Iiri T. The expanding spectrum of G protein diseases. N Engl J Med. 1999;340:1012–1020.
Losel RM, Falkenstein E, Feuring M, et al. Nongenomic steroid action: Controversies, questions, and answers. Physiol Rev. 2003;83:965–1016.
Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol. 2010;204:105–114.
Melmed S, Polonsky KS, Larsen PR, Kronenberg HM. Williams Textbook of Endocrinology. 12th ed. Saunders: Philadelphia; 2012.
Missale C, Nash SR, Robinson SW, et al. Dopamine receptors: From structure to function. Physiol Rev. 1998;78:189–225.
Scatchard G. The attraction of proteins for small molecules and ions. Ann N Y Acad Sci. 1949;51:660–672.
Sutherland EW, Robison GA. The role of cyclic-3′,5′-AMP in responses to catecholamines and other hormones. Pharmacol Rev. 1966;18:145–161.
Wettschureck N, Offermanns S. Mammalian G proteins and their cell type specific functions. Physiol Rev. 2005;85:1159–1204.
Berson SA, Yalow RS. Assay of insulin in human subjects by immunological methods. Nature. 1959;184:1948–1949.
Brouckaert O, Paridaens R, Floris G, et al. A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative. Ann Oncol. 2013;24:47–53.
DeLellis RA, Xia L. Paraneoplastic endocrine syndromes: A review. Endocr Pathol. 2003;12:303–318.
Elgin RC, Busby WL, Clemmons DR. An insulin-like growth factor binding protein enhances the biological response to IGF-1. Proc Natl Acad Sci U S A. 1987;84:3254–3258.
Upton GV, Amatruda TT Jr. Evidence for the presence of tumor peptides with corticotropin-releasing-factor–like activity in the ectopic ACTH syndrome. N Engl J Med. 1971;285:419–424.
Yu D, Yu S, Schuster V, et al. Identification of two novel deletion mutations within the Gs alpha gene (GNAS1) in Albright hereditary osteodystrophy. J Clin Endocrinol Metab. 1999;84:3254–3259.